Patients
On addressing drug waste and ensuring access, with Jeff Harp...
The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.
R&D
AMR and vaccines: Can universal coverage avert a post-antibi...
Antimicrobial resistance (AMR) is a growing global health crisis.
Patients
Sponsored
From insight to impact: Why the patient voice will redefine ...
Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?
R&D
Treating the chronic diseases GLP-1s miss, with Laurent Auda...
Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
R&D
Changing Faces: Pharma and biotech, January 2026
The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
